World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), 

Abstract

THE IMPACT OF STIMULANTS ON THE CARDIOVASCULAR AND METABOLIC RISKS IN ADULT PATIENTS WITH ADHD: EMPHASIS ON CHOLESTEROL PROFILE CHANGES

Dr. Adel Gabriel*, Moheb Basta and Mona Nematian

ABSTRACT

Objective: The objective of this study is to examine the impact of central nervous stimulants on the cardiovascular and metabolic risks in adult ADHD patients. Method: Participated in this study, consenting male and female consecutive outpatients with confirmed ADHD diagnosis. All patients received either amphetamine or methylphenidate stimulant treatments for 12 weeks. The primary outcome measure included the lipid profile measures. Other clinical outcome measures included; resting heart rate, systolic and diastolic blood pressure, weight, BMI, fasting glucose, and HBA1C. Cholesterol profile measures and other cardiovascular risk measures were gathered once before the stimulants were initiated and 12 weeks after continuous treatment. Symptom frequency changes were measured by completing the "Adult ADHD self report scale - ASRS-v1.1" before and 12 weeks after treatment. The study was granted approval by the Conjoint Scientific and Ethics Board at the University of Calgary. Results: The paired t test, was utilized to examine changes in cholesterol and other cardiovascular risk variables. After 12 weeks of stimulant treatment, there was significant reduction (p < .01) in the LDL-C measure but there were no significant decrease in any of the other lipid measures, there was significant decrease (p < .001) in weight, and in BMI. There were no significant changes in fasting glucose, or in HBA1C parameters. Employing ANOVA, there was significant (p< .001) decrease in the ASRS-vi.i, self report scale scores at 12 weeks. Conclusion: Stimulants used in adults with ADHD are associated with minor, but statistically significant and favorable changes in the LDL-C lipoprotein. However, there was no significant changes in the overall cardiac risk as measured by the Framingham Risk Score (FRS). It is concluded from reviewing literature that the overall cardiovascular risk seemed to be dependent on number of factors, including but not limited to, genetic, environmental, biochemical factors, as well as on the interaction with other disease status variables.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here